These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 35980134)

  • 61. Computational flow cytometry provides accurate assessment of measurable residual disease in chronic lymphocytic leukaemia.
    Nguyen PC; Nguyen V; Baldwin K; Kankanige Y; Blombery P; Came N; Westerman DA
    Br J Haematol; 2023 Aug; 202(4):760-770. PubMed ID: 37052611
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Normal levels of peripheral CD19(+) CD5(+) CLL-like cells: toward a defined threshold for CLL follow-up -- a GEIL-GOELAMS study.
    Durrieu F; Geneviève F; Arnoulet C; Brumpt C; Capiod JC; Degenne M; Feuillard J; Garand R; Kara-Terki A; Kulhein E; Maynadié M; Ochoa-Noguera ME; Plesa A; Roussel M; Eghbali H; Truchan-Graczyk M; de Carvalho Bittencourt M; Feugier P; Béné MC
    Cytometry B Clin Cytom; 2011 Nov; 80(6):346-53. PubMed ID: 21976156
    [TBL] [Abstract][Full Text] [Related]  

  • 63. PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal Relatedness.
    He R; Ding W; Viswanatha DS; Chen D; Shi M; Van Dyke D; Tian S; Dao LN; Parikh SA; Shanafelt TD; Call TG; Ansell SM; Leis JF; Mai M; Hanson CA; Rech KL
    Am J Surg Pathol; 2018 Jul; 42(7):843-854. PubMed ID: 29762141
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Quantitative assessment of informative immunophenotypic markers increases the diagnostic value of immunophenotyping in mature CD5-positive B-cell neoplasms.
    Starostka D; Kriegova E; Kudelka M; Mikula P; Zehnalova S; Radvansky M; Papajik T; Kolacek D; Chasakova K; Talianova H
    Cytometry B Clin Cytom; 2018 Jul; 94(4):576-587. PubMed ID: 29220870
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Primary cutaneous lymphomas in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): A series of 12 cases.
    Liu YA; Finn AJ; Subtil A
    J Cutan Pathol; 2021 May; 48(5):617-624. PubMed ID: 33415780
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Minimal Residual Disease in Chronic Lymphocytic Leukemia: A New Goal?
    Del Giudice I; Raponi S; Della Starza I; De Propris MS; Cavalli M; De Novi LA; Cappelli LV; Ilari C; Cafforio L; Guarini A; Foà R
    Front Oncol; 2019; 9():689. PubMed ID: 31555576
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Case report: Chronic lymphocytic leukemia/small lymphocytic lymphoma and monomorphic epitheliotropic intestinal T-cell lymphoma: A composite lymphoma.
    Zhang B; Zhang Y; Li Q; Jiang Q; Chu W; Gong H; Li R; Ji H
    Pathol Oncol Res; 2022; 28():1610653. PubMed ID: 36567979
    [No Abstract]   [Full Text] [Related]  

  • 68. Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders.
    Cabezudo E; Carrara P; Morilla R; Matutes E
    Haematologica; 1999 May; 84(5):413-8. PubMed ID: 10329919
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Predictive value of blood and bone marrow flow cytometry in B-cell lymphoma classification: comparative analysis of flow cytometry and tissue biopsy in 252 patients.
    Morice WG; Kurtin PJ; Hodnefield JM; Shanafelt TD; Hoyer JD; Remstein ED; Hanson CA
    Mayo Clin Proc; 2008 Jul; 83(7):776-85. PubMed ID: 18613994
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Composite Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia and Follicular Lymphoma: A Clinicopathological Study of Six Cases.
    Jelloul FZ; Chen QH; Yang T; Haghi N; Brody J; Zhang X; Sheikh-Fayyaz S
    Int J Surg Pathol; 2018 Apr; 26(2):135-144. PubMed ID: 29069998
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A new score including CD43 and CD180: Increased diagnostic value for atypical chronic lymphocytic leukemia.
    Li Y; Tong X; Huang L; Li L; Wang C; He C; Liu S; Wang Z; Xiao M; Mao X; Zhang D
    Cancer Med; 2021 Jul; 10(13):4387-4396. PubMed ID: 34061467
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Immunophenotype does not correlate with lymph node histology in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Asplund SL; McKenna RW; Howard MS; Kroft SH
    Am J Surg Pathol; 2002 May; 26(5):624-9. PubMed ID: 11979092
    [TBL] [Abstract][Full Text] [Related]  

  • 73. NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphoma.
    Parry HM; Stevens T; Oldreive C; Zadran B; McSkeane T; Rudzki Z; Paneesha S; Chadwick C; Stankovic T; Pratt G; Zuo J; Moss P
    Oncotarget; 2016 Oct; 7(42):68513-68526. PubMed ID: 27655680
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A 10-color flow cytometry panel for diagnosis and minimal residual disease in chronic lymphocytic leukemia.
    Bazinet A; Rys RN; Barry A; Greenwood CMT; Young YK; Mendoza A; LaPorta I; Wever CM; Mercier FE; Johnson NA
    Leuk Lymphoma; 2021 Oct; 62(10):2352-2359. PubMed ID: 34020575
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Frontline Treatment for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Targeted Therapy vs. Chemoimmunotherapy.
    Small S; Ma S
    Curr Hematol Malig Rep; 2021 Aug; 16(4):325-335. PubMed ID: 34021874
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Chronic lymphocytic leukemia/small lymphocytic lymphoma associated with IgM paraprotein.
    Yin CC; Lin P; Carney DA; Handy BC; Rassidakis GZ; Admirand JH; Keating MJ; Medeiros LJ
    Am J Clin Pathol; 2005 Apr; 123(4):594-602. PubMed ID: 15743747
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Chronic lymphocytic leukemia and small lymphocytic lymphoma: two faces of the same disease.
    Tees MT; Flinn IW
    Expert Rev Hematol; 2017 Feb; 10(2):137-146. PubMed ID: 27936980
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with prolonged survival.
    Moreton P; Kennedy B; Lucas G; Leach M; Rassam SM; Haynes A; Tighe J; Oscier D; Fegan C; Rawstron A; Hillmen P
    J Clin Oncol; 2005 May; 23(13):2971-9. PubMed ID: 15738539
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A comparison of the sensitivity of flow cytometry and bone marrow biopsy in the detection of minimal residual disease in chronic lymphocytic leukemia.
    Maloum K; Charlotte F; Divine M; Cazin B; Lesty C; Merle-Béral H;
    Haematologica; 2006 Jun; 91(6):860-1. PubMed ID: 16769593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.